FDA WIll Install Abbott's (ABT) STARLIMS LIMS Technology in Testing Labs
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Join SI Premium – FREE
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration (FDA) will begin implementing Abbott's STARLIMS® software-based laboratory information management system (LIMS) as part of the agency's initiative to enhance FDA testing laboratories.
STARLIMS LIMS software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories.
As part of a master agreement with Dovel Technologies, a company that provides high-end software applications to government organizations, the FDA's Office of Regulatory Affairs (ORA) will begin deploying LIMS solutions from STARLIMS, designed to enhance testing of food and drug chemistries, devices, forensics material and microbiology samples. The ORA operates mainly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytical workflow operations in ORA labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
STARLIMS LIMS software will be used to manage complex processes and the analysis of the vast amounts of information generated by FDA laboratories.
As part of a master agreement with Dovel Technologies, a company that provides high-end software applications to government organizations, the FDA's Office of Regulatory Affairs (ORA) will begin deploying LIMS solutions from STARLIMS, designed to enhance testing of food and drug chemistries, devices, forensics material and microbiology samples. The ORA operates mainly five types of laboratories in 14 separate locations. The LIMS solution will provide the needed capability to manage the analytical workflow operations in ORA labs for approximately 825 users supporting sample accountability, data analysis, document control, report generation, and other lab operation functions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott Labs (ABT) PT Raised to $135 at TD Cowen
- Agroz faces Nasdaq delisting over bid price and filing failures
- Space-Eyes names four directors ahead of planned Nasdaq listing
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
